Svolacchia Fabiano, Svolacchia Lorenzo, Falabella Patrizia, Scieuzo Carmen, Salvia Rosanna, Giglio Fabiana, Catalano Alessia, Saturnino Carmela, Di Lascio Pierpaolo, Guarro Giuseppe, Imbriani Giusy Carmen, Ferraro Giuseppe, Giuzio Federica
Department of Sense Organs, University of Rome "La Sapienza", 00184 Rome, Italy.
Department of General Surgery, University of Rome "La Sapienza", 00184 Rome, Italy.
Medicina (Kaunas). 2024 Apr 21;60(4):670. doi: 10.3390/medicina60040670.
: This three-year clinical trial aimed to demonstrate that only the signaling vesicles produced by ADSCa, containing mRNA, microRNA, growth factors (GFs), and bioactive peptides, provide an advantage over classical therapy with adipose disaggregate to make the tissue regeneration technique safer due to the absence of interfering materials and cells, while being extremely minimally invasive. The infiltration of disaggregated adipose nanofat, defined by the Tonnard method, for the regeneration of the dermis and epidermis during physiological or pathological aging continues to be successfully used for the presence of numerous adult stem cells in suspension (ADSCa). An improvement in this method is the exclusion of fibrous shots and cellular debris from the nanofat to avoid inflammatory phenomena by microfiltration. : A small amount of adipose tissue was extracted after surface anesthesia and disaggregated according to the Tonnard method. An initial microfiltration at 20/40 microns was performed to remove fibrous shots and cellular debris. The microfiltration was stabilized with a sterile solution containing hyaluronic acid and immediately ultrafiltered to a final size of 0.20 microns to exclude the cellular component and hyaluronic acid chains of different molecular weights. The suspension was then injected into the dermis using a mesotherapy technique with microinjections. : This study found that it is possible to extract signaling microvesicles using a simple ultrafiltration system. The Berardesca Scale, Numeric Rating Scale (NRS), and Modified Vancouver Scale (MVS) showed that it is possible to obtain excellent results with this technique. The ultrafiltrate can validly be used in a therapy involving injection into target tissues affected by chronic and photoaging with excellent results. : This retrospective clinical evaluation study allowed us to consider the results obtained with this method for the treatment of dermal wrinkles and facial tissue furrows as excellent. The method is safe and an innovative regenerative therapy as a powerful and viable alternative to skin regeneration therapies, antiaging therapies, and chronic inflammatory diseases because it lacks the inflammatory component produced by cellular debris and fibrous sprouts and because it can exclude the mesenchymal cellular component by reducing multiple inflammatory cytokine levels.
这项为期三年的临床试验旨在证明,只有脂肪来源的分泌囊泡(ADSCa)产生的信号囊泡,包含信使核糖核酸(mRNA)、微小核糖核酸(microRNA)、生长因子(GFs)和生物活性肽,与传统的脂肪分解疗法相比具有优势,由于不存在干扰物质和细胞,使得组织再生技术更安全,同时具有极小的侵入性。由托纳德(Tonnard)方法定义的分解脂肪纳米脂肪,用于生理性或病理性衰老过程中真皮和表皮的再生,由于悬浮液中存在大量成体干细胞(ADSCa),该方法仍在成功使用。此方法的改进之处在于通过微滤从纳米脂肪中排除纤维碎片和细胞碎片,以避免炎症现象。
在表面麻醉后提取少量脂肪组织,并根据托纳德方法进行分解。首先进行20/40微米的微滤以去除纤维碎片和细胞碎片。用含有透明质酸的无菌溶液稳定微滤过程,然后立即超滤至最终尺寸为0.20微米,以排除细胞成分和不同分子量的透明质酸链。然后使用微注射的中胚层疗法技术将悬浮液注入真皮。
本研究发现,使用简单的超滤系统可以提取信号微囊泡。贝拉尔代斯卡量表(Berardesca Scale)、数字评分量表(Numeric Rating Scale,NRS)和改良温哥华量表(Modified Vancouver Scale,MVS)表明,使用该技术可以获得优异的结果。超滤物可有效地用于涉及注射到受慢性和光老化影响的靶组织的治疗中,效果极佳。
这项回顾性临床评估研究使我们认为,用这种方法治疗皮肤皱纹和面部组织皱纹所取得的结果非常出色。该方法是一种安全且创新的再生疗法,是皮肤再生疗法、抗衰老疗法和慢性炎症性疾病的强大且可行的替代方案,因为它缺乏细胞碎片和纤维芽产生的炎症成分,并且可以通过降低多种炎症细胞因子水平来排除间充质细胞成分。